Streetbeat News

Products Services

CVM

CEL-SCI Corporation (NYSE:CVM) has announced that its immunotherapy drug Multikine has increased 5-year survival rates from 45% to 73% in its target population of head and neck cancer patients. The company has finalized the selection criteria for this target population and plans to seek immediate approval for commercial distribution. Pre-application regulatory filings have been submitted in the UK and Europe, with additional filings planned in the U.S. and Canada.

Portfolio Pulse from Happy Mohamed

October 23, 2023 | 1:16 pm

IBRX

ImmunityBio has resubmitted its Biological License Application for N-803, a treatment for BCG-unresponsive non-muscle-invasive bladder cancer carcinoma-in-situ. The company's stock, IBRX, may be affected by this news.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:07 pm

APLM

ARVN

LMDX

LumiraDx (LMDX) partners with AstraZeneca and Everton in the Community to set up England's first heart and lung screening hub, causing its stock to surge by 387%. Apollomics (APLM) announces 75% overall response rate in NSCLC patients with MetEx14 Skipping Mutation from Vebreltinib, leading to a 34% increase in its stock. Arvinas (ARVN) reports positive interim data from second generation ARV-766 in mCRPC, reinforcing the potential of its PROTAC® AR Degraders and causing a 9% rise in its stock.

Portfolio Pulse from ryanfaloona@benzinga.com

October 23, 2023 | 12:56 pm

ASLE

DCO

SPCE

SpaceX, the aerospace manufacturer founded by Elon Musk, has won a key satellite launch deal with the European Space Agency (ESA). The deal will facilitate the launch of several European navigation and secure communication satellites. The U.S.-based Falcon 9 rockets will take the satellites into space. This contract marks the first time EU institutions have sought SpaceX's expertise to launch satellites equipped with classified gear.

Portfolio Pulse from Shivani Kumaresan

October 23, 2023 | 12:53 pm

SYTA

Siyata Mobile Inc. has entered into a distribution agreement with GetWireless LLC for its SD7 handsets and accessories. This agreement will expand access to Siyata's products in the U.S. through GetWireless' partner programs.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 12:46 pm

RVMD

Revolution Medicines has announced the presentation of clinical activity and safety data from its Phase 1/1b trial of RMC-6236. Following the announcement, the company's shares are trading lower.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 12:45 pm

Mastercard has expanded its consulting services with the addition of AI and Economics practices and Digital Labs. These new services are aimed at providing fast-tracked solutions to clients.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 12:45 pm

DDD

Icon Technologies Limited, a thermoforming and rotational molding company, has purchased an EXT 1270 Titan Pellet 3D printer from 3D Systems (NYSE:DDD). The printer is expected to significantly reduce lead time and cost associated with mold production. Icon is the first manufacturer in Canada to integrate this 3D printer into its production workflow. The EXT 1270 Titan Pellet system is designed to leverage low-cost thermoplastic pellet feedstocks and can print large thermoforming tools, such as those required by Icon.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 12:44 pm

JAGX

Jaguar Health and Filament Health Corp.'s joint venture, Magdalena Biosciences, has initiated a preclinical study to evaluate plant extracts for the treatment of depression, anxiety, ADHD, and other mental health indications.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 12:38 pm

AMZN

BTCUSD

ETHUSD

GOOGL

INTC

SPY

TSLA

The article covers a range of topics including upcoming Q3 earnings for Amazon, Alphabet, Meta, and Intel, the ongoing trial of Sam Bankman-Fried, and the performance of various cryptocurrencies. It also discusses political developments in the US, the potential for a recession in the US economy next year, and tech news including a rumored 32-inch iMac Pro and Tesla's entry into India.

Portfolio Pulse from Akanksha Bakshi

October 23, 2023 | 12:34 pm